Morphological and immunophenotypic variations in malignant melanoma
- PMID: 10792480
- DOI: 10.1046/j.1365-2559.2000.00894.x
Morphological and immunophenotypic variations in malignant melanoma
Abstract
A variety of cytomorphological features, architectural patterns and stromal changes may be observed in malignant melanomas. Hence, melanomas may mimic carcinomas, sarcomas, benign stromal tumours, lymphomas, plasmacytomas and germ cell tumours. Melanomas may be composed of large pleomorphic cells, small cells, spindle cells and may contain clear, signet-ring, pseudolipoblastic, rhabdoid, plasmacytoid or balloon cells. Various inclusions and phagocytosed material may be present in their cytoplasm. Nuclei may show bi- or multi-nucleation, lobation, inclusions, grooving and angulation. Architectural variations include fasciculation, whorling, nesting, trabeculation, pseudoglandular/pseudopapillary/pseudofollicular, pseudorosetting and angiocentric patterns. Myxoid or desmoplastic changes and very rarely pseudoangiosarcomatous change, granulomatous inflammation or osteoclastic giant cell response may be seen in the stroma. The stromal blood vessels may exhibit a haemangiopericytomatous pattern, proliferation of glomeruloid blood vessels and perivascular hyalinization. Occasionally, differentiation to nonmelanocytic structures (Schwannian, fibro-/myofibroblastic, osteocartilaginous, smooth muscle, rhabdomyoblastic, ganglionic and ganglioneuroblastic) may be observed. Typically melanomas are S100 protein, NKIC3, HMB-45, Melan-A and tyrosinase positive but some melanomas may exhibit an aberrant immunophenotype and may express cytokeratins, desmin, smooth muscle actin, KP1 (CD68), CEA, EMA and VS38. Very rarely, neurofilament protein and GFAP positivity may be seen.
Similar articles
-
Immunoprofile of MITF, tyrosinase, melan-A, and MAGE-1 in HMB45-negative melanomas.Am J Surg Pathol. 2002 Jan;26(1):82-7. doi: 10.1097/00000478-200201000-00010. Am J Surg Pathol. 2002. PMID: 11756773
-
Cutaneous amelanotic signet-ring cell malignant melanoma with interspersed myofibroblastic differentiation in a young cat.J Vet Diagn Invest. 2016 Jul;28(4):429-35. doi: 10.1177/1040638716644768. Epub 2016 May 6. J Vet Diagn Invest. 2016. PMID: 27154314
-
KBA62 and PNL2: 2 new melanoma markers-immunohistochemical analysis of 1563 tumors including metastatic, desmoplastic, and mucosal melanomas and their mimics.Am J Surg Pathol. 2012 Feb;36(2):265-72. doi: 10.1097/PAS.0b013e31823651cb. Am J Surg Pathol. 2012. PMID: 22067329 Free PMC article.
-
Divergent differentiation in malignant melanomas: a review.Histopathology. 2008 Jan;52(2):119-29. doi: 10.1111/j.1365-2559.2007.02823.x. Epub 2007 Sep 7. Histopathology. 2008. PMID: 17825057 Review.
-
Malicious masquerade: myxoid melanoma.Semin Diagn Pathol. 1998 Aug;15(3):195-202. Semin Diagn Pathol. 1998. PMID: 9711669 Review.
Cited by
-
Malignant Melanoma of Anorectum: Two Case Reports.Ann Coloproctol. 2021 Feb;37(1):65-70. doi: 10.3393/ac.2020.01.07.1. Epub 2021 Feb 28. Ann Coloproctol. 2021. PMID: 33730798 Free PMC article.
-
Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function.PLoS One. 2011 Apr 15;6(4):e18784. doi: 10.1371/journal.pone.0018784. PLoS One. 2011. PMID: 21526207 Free PMC article.
-
Could it still be malignant melanoma or just a poorly differentiated neoplasm?BMJ Case Rep. 2009;2009:bcr11.2008.1259. doi: 10.1136/bcr.11.2008.1259. Epub 2009 Jul 7. BMJ Case Rep. 2009. PMID: 21734912 Free PMC article.
-
UVB mutagenesis differs in Nras- and Braf-mutant mouse models of melanoma.Life Sci Alliance. 2021 Jul 1;4(9):e202101135. doi: 10.26508/lsa.202101135. Print 2021 Sep. Life Sci Alliance. 2021. PMID: 34210801 Free PMC article.
-
Diagnostic and prognostic biomarkers in melanoma.J Clin Aesthet Dermatol. 2014 Jun;7(6):13-24. J Clin Aesthet Dermatol. 2014. PMID: 25013535 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous